- Home
- HRMY vs OSW Comparison
HRMY vs OSW Comparison
Compare HRMY & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- OSW
- Stock Information
- Founded
- HRMY 2017
- OSW 2017
- Country
- HRMY United States
- OSW Bahamas
- Employees
- HRMY N/A
- OSW N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- OSW Hotels/Resorts
- Sector
- HRMY Health Care
- OSW Consumer Discretionary
- Exchange
- HRMY Nasdaq
- OSW Nasdaq
- Market Cap
- HRMY 1.8B
- OSW 2.1B
- IPO Year
- HRMY 2020
- OSW N/A
- Fundamental
- Price
- HRMY $34.00
- OSW $21.37
- Analyst Decision
- HRMY Strong Buy
- OSW Strong Buy
- Analyst Count
- HRMY 9
- OSW 4
- Target Price
- HRMY $54.44
- OSW $21.25
- AVG Volume (30 Days)
- HRMY 653.9K
- OSW 541.9K
- Earning Date
- HRMY 08-05-2025
- OSW 07-30-2025
- Dividend Yield
- HRMY N/A
- OSW 0.74%
- EPS Growth
- HRMY 13.13
- OSW 84.76
- EPS
- HRMY 2.62
- OSW 0.63
- Revenue
- HRMY $744,852,000.00
- OSW $903,423,000.00
- Revenue This Year
- HRMY $20.33
- OSW $7.54
- Revenue Next Year
- HRMY $17.67
- OSW $8.16
- P/E Ratio
- HRMY $12.97
- OSW $33.84
- Revenue Growth
- HRMY 20.62
- OSW 9.80
- 52 Week Low
- HRMY $26.47
- OSW $14.21
- 52 Week High
- HRMY $41.61
- OSW $23.01
- Technical
- Relative Strength Index (RSI)
- HRMY 58.91
- OSW 66.07
- Support Level
- HRMY $31.70
- OSW $21.04
- Resistance Level
- HRMY $35.08
- OSW $21.84
- Average True Range (ATR)
- HRMY 0.95
- OSW 0.56
- MACD
- HRMY 0.27
- OSW 0.09
- Stochastic Oscillator
- HRMY 71.80
- OSW 83.21
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.